Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $456.29 | 24 | 93.5% |
| Education | $31.83 | 2 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $96.37 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $84.15 | 6 | $0 (2020) |
| Intuitive Surgical, Inc. | $63.71 | 1 | $0 (2018) |
| Horizon Therapeutics plc | $57.30 | 3 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $42.99 | 2 | $0 (2019) |
| Relypsa, Inc. | $38.12 | 2 | $0 (2020) |
| Lilly USA, LLC | $20.90 | 1 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $18.55 | 1 | $0 (2023) |
| Boston Scientific Corporation | $17.67 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.97 | 2 | Lilly USA, LLC ($20.90) |
| 2023 | $158.96 | 9 | GlaxoSmithKline, LLC. ($60.18) |
| 2022 | $28.26 | 2 | GlaxoSmithKline, LLC. ($16.12) |
| 2021 | $30.96 | 2 | Aurinia Pharma U.S., Inc. ($19.69) |
| 2020 | $65.84 | 4 | Relypsa, Inc. ($38.12) |
| 2019 | $35.83 | 2 | Mallinckrodt Enterprises LLC ($19.49) |
| 2018 | $87.24 | 3 | Intuitive Surgical, Inc. ($63.71) |
| 2017 | $40.06 | 2 | Mallinckrodt LLC ($23.50) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/25/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: KRYSTEXXA | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: NEPHROLOGY | ||||||
| 09/08/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: KRYSTEXXA | ||||||
| 07/25/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.55 | General |
| 03/16/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2023 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Varithena_PI | ||||||
| 10/26/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $12.14 | General |
| 10/07/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/12/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: KRYSTEXXA | ||||||
| 12/17/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Hyperkalemia | ||||||
| 06/03/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEPHROLOGY | ||||||
| 03/31/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Hyperkalemia | ||||||
| 02/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEPHROLOGY | ||||||
| 04/03/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/07/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: NEPHROLOGY | ||||||
| 08/09/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2018 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $63.71 | General |
| Category: SURGERY | ||||||
| 08/31/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 898 | 2,194 | $683,951 | $225,421 |
| 2022 | 11 | 954 | 2,363 | $540,812 | $228,512 |
| 2021 | 9 | 1,179 | 2,889 | $517,508 | $264,522 |
| 2020 | 8 | 1,244 | 3,013 | $584,985 | $282,926 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 205 | 695 | $176,896 | $62,828 | 35.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 28 | 202 | $159,288 | $54,098 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 440 | $74,450 | $26,522 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 419 | $103,160 | $26,220 | 25.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 149 | 195 | $79,179 | $25,898 | 32.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 14 | 80 | $36,802 | $11,864 | 32.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 22 | 42 | $28,148 | $9,301 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $12,416 | $4,732 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 83 | $13,611 | $3,960 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 249 | 741 | $126,748 | $57,823 | 45.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 35 | 204 | $135,251 | $55,449 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 475 | $83,321 | $32,011 | 38.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 134 | 585 | $80,006 | $31,783 | 39.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 156 | 188 | $56,550 | $28,260 | 50.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 22 | 46 | $26,360 | $10,637 | 40.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 22 | $10,481 | $3,517 | 33.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 20 | $8,000 | $3,338 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,623 | $2,668 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 47 | $6,240 | $1,983 | 31.8% |
| 99218 | Initial hospital observation care per day, typically 30 minutes | Facility | 2022 | 13 | 14 | $2,233 | $1,043 | 46.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 239 | 804 | $120,588 | $64,544 | 53.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 36 | 217 | $119,350 | $59,617 | 50.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 240 | 915 | $109,800 | $50,986 | 46.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 191 | 230 | $55,200 | $35,768 | 64.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 254 | $33,020 | $18,791 | 56.9% |
About Dr. Salman Butt, M.D
Dr. Salman Butt, M.D is a Nephrology healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760664585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Salman Butt, M.D has received a total of $488.12 in payments from pharmaceutical and medical device companies, with $40.97 received in 2024. These payments were reported across 26 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($456.29).
As a Medicare-enrolled provider, Butt has provided services to 4,275 Medicare beneficiaries, totaling 10,459 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Mckinney, TX
- Active Since 12/04/2007
- Last Updated 07/20/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760664585
Products in Payments
- BENLYSTA (Biological) $83.52
- JYNARQUE (Drug) $67.59
- Da Vinci Surgical System (Device) $63.71
- KRYSTEXXA (Biological) $57.30
- ACTHAR (Biological) $42.99
- Veltassa (Drug) $38.12
- JARDIANCE (Drug) $20.90
- LUPKYNIS (Drug) $19.69
- Varithena Administration Pack (Device) $17.67
- SAMSCA (Drug) $16.56
- Velphoro (Drug) $16.53
- JESDUVROQ (Drug) $12.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Mckinney
Vinay Acharya
Nephrology — Payments: $4,779
Dr. Syed Asghar, M.d, M.D
Nephrology — Payments: $4,221
Obiajulu Kanu, Md, MD
Nephrology — Payments: $2,994
Dr. Wajeeha Sindhu, Do, DO
Nephrology — Payments: $1,368
Mohammad Sadeddin, M.d, M.D
Nephrology — Payments: $878.15
Rehana Saquib, Md, MD
Nephrology — Payments: $610.32